Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

UPDATE On the RISK of SECONDARY LEUKEMIA In GENETIC SUBGROUPS ( ELANE , HAX1, WAS, G6PC3, p14 ) of CONGENITAL NEUTROPENIA In EUROPE

Cornelia Zeidler, MD, Peter Vandenberghe, MD, PhD, Irina Schäfer, Ludwig Hoy, Martin Zimmermann, PhD, Manuela Germeshausen, PhD, Karl Welte, MD

Blood (2011) 118 (21): 1106.

https://doi.org/10.1182/blood.V118.21.1106.1106

Published: 2011

Journal Articles

Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup.

Jürgen Krauter, MD, Katharina Wagner, M.D., Irina Schäfer, Rolf Marschalek, Ph.D., Claus Meyer, M.D., Gerhard Heil, M.D., Markus Andreas Schaich, M.D., Gerhard Ehninger, M.D., Dietger W. Niederwieser, M.D., Rainer Krahl, M.D., Thomas Buchner, M.D., Cristina Sauerland, Brigitte Schlegelberger, M.D., Konstanze Dohner, M.D., Hartmut Dohner, M.D., Richard Schlenk, M.D., Arnold Ganser, M.D.

Blood (2007) 110 (11): 759.

https://doi.org/10.1182/blood.V110.11.759.759

Published: 2007

Journal Articles

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the German AML-Intergroup.

Jürgen Krauter, MD, Katharina Wagner, M.D., Irina Schäfer, Rolf Marschalek, Ph.D., Claus Meyer, M.D., Gerhard Heil, M.D., Markus Andreas Schaich, M.D., Gerhard Ehninger, M.D., Dietger W. Niederwieser, M.D., Rainer Krahl, M.D., Konstanze Dohner, M.D., Hartmut Dohner, M.D., Richard Schlenk, M.D., Arnold Ganser, M.D.

Blood (2006) 108 (11): 16.

https://doi.org/10.1182/blood.V108.11.16.16

Published: 2006

Journal Articles

Gene Mutations as Predicitive Markers for Postremission Therapy in Younger Adults with Normal Karyotype AML.

Richard F. Schlenk, MD, Andrea Corbacioglu, MD, Jürgen Krauter, MD, Lars Bullinger, MD, Michael Morgan, MD, Daniela Späth, MD, Irina Schäfer, MD, Stefan Frohling, MD, Arnold Ganser, MD, Hartmut Dohner, MD, Konstanze Dohner, MD

Blood (2006) 108 (11): 4.

https://doi.org/10.1182/blood.V108.11.4.4

Published: 2006

Journal Articles

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the AML-SG and SHG-Dresden Study Groups.

Jürgen Krauter, MD, Irina Schäfer, Anke Kohlenberg, MD, Katharina Wagner, MD, Gerhard Heil, MD, Markus Schaich, MD, Gerhard Ehninger, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Richard Schlenk, MD, Arnold Ganser, MD

Blood (2005) 106 (11): 2360.

https://doi.org/10.1182/blood.V106.11.2360.2360

Published: 2005

Journal Articles

Impact of Different Postremission Strategies in Younger Adults with Acute Myeloid Leukemia and Normal Karyotype Exhibiting a CEBPA Mutation.

Richard F. Schlenk, MD, Andrea Corbacioglu, PhD, Stefan Fröhling, MD, Juan Du, MD, Daniela Späth, Irina Schäfer, Jürgen Krauter, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Konstanze Döhner, MD, for the German-Austrian, AML Study Group (AMLSG)

Blood (2005) 106 (11): 2352.

https://doi.org/10.1182/blood.V106.11.2352.2352

Published: 2005

Journal Articles

Postremission Therapy with an Allogeneic Transplantation from an HLA-Matched Family Donor Seems To Overcome the Negative Prognostic Impact of FLT3 -ITD in Younger Patients with Acute Myeloid Leukemia Exhibiting a Normal Karyotype.

Richard F. Schlenk, MD, Jürgen Krauter, MD, Stefan Fröhling, MD, Daniela Späth, Irina Schäfer, MD, Stefan Hein, Hartmut Döhner, MD, Arnold Ganser, MD, Konstanze Döhner, MD, for the German-Austrian AML Study Group (AMLSG)

Blood (2005) 106 (11): 2353.

https://doi.org/10.1182/blood.V106.11.2353.2353

Published: 2005

Journal Articles

Allogeneic Transplantation from an HLA-Matched Family Donor in First Complete Remission of Acute Myeloid Leukemia Had an Adverse Impact on Quality of Life in Patients Followed for at Least Five Years after Treatment: A Survey of the German AML Intergroup on 525 Patients.

Dorle Messerer, PhD, Jutta Engel, MD, Jörg Hasford, PhD, Markus Schaich, MD, Silke Soucek, Gerhard Ehninger, MD, Christina Sauerland, PhD, Thomas Büchner, MD, Dietger W. Niederwieser, MD, Rainer Krahl, MD, Jürgen Krauter, MD, Irina Schäfer, Arnold Ganser, MD, Claire Schleich, Hartmut Döhner, MD, Richard F. Schlenk, MD

Blood (2005) 106 (11): 747.

https://doi.org/10.1182/blood.V106.11.747.747

Published: 2005

NARROW

UPDATE On the RISK of SECONDARY LEUKEMIA In GENETIC SUBGROUPS ( ELANE , HAX1, WAS, G6PC3, p14 ) of CONGENITAL NEUTROPENIA In EUROPE

Prognostic Factors in Adult Patients up to 60 Years with AML and Translocations of Chromosome 11q23: Individual Patient Data Based Analysis of the German AML-Intergroup.

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the German AML-Intergroup.

Gene Mutations as Predicitive Markers for Postremission Therapy in Younger Adults with Normal Karyotype AML.

Prognosis of Adult Patients ≤60 Years with AML and Aberrations of Chromosome 11q23: Pooled Data Analysis of the AML-SG and SHG-Dresden Study Groups.

Impact of Different Postremission Strategies in Younger Adults with Acute Myeloid Leukemia and Normal Karyotype Exhibiting a CEBPA Mutation.

Postremission Therapy with an Allogeneic Transplantation from an HLA-Matched Family Donor Seems To Overcome the Negative Prognostic Impact of FLT3 -ITD in Younger Patients with Acute Myeloid Leukemia Exhibiting a Normal Karyotype.

Allogeneic Transplantation from an HLA-Matched Family Donor in First Complete Remission of Acute Myeloid Leukemia Had an Adverse Impact on Quality of Life in Patients Followed for at Least Five Years after Treatment: A Survey of the German AML Intergroup on 525 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only